You are here

Shelly R Nason

Graduate Research Assistant
Department of Medicine
Division of Endocrinology, Diabetes, and Metabolism
University of Alabama at Birmingham
Birmingham, Alabama 35294
Full CV

Shelly received a Bachelor of Science in Molecular Biology and Biotechnology from the University of Michigan – Flint in 2015. Her undergraduate research focused on stressors that regulate breast cancer metastasis. In 2015, Shelly started in the Cancer Biology PhD program at UAB and later joined Kirk Habegger’s lab. Her current research is focused on the fasting hormone glucagon as an anti-obesity therapeutic and its downstream mediators of energy balance, including liver circadian genes and the liver leptin receptor.


  • Xu X, Garcia J, Ewalt R, Nason S and Pozzo-Miller L (2017) The BDNF val-66-met Polymorphism Affects Neuronal Morphology and Synaptic Transmission in Cultured Hippocampal Neurons from Rett Syndrome Mice. Front. Cell. Neurosci. 11:203. [doi: 10.3389/fncel.2017.00203]


  • Third place oral presentation at Graduate Biomedical Sciences Symposium (2017)


  • Glucagon-Receptor Signaling Alters Liver Clock Genes in DIO Mice. Invited oral presentation at the GBS Annual Symposium; Aug 4, 2017.
  • Glucagon-Receptor Signaling Regulates Hepatic Leptin Receptor Expression. Invited oral presentation at UAB Diabetes Day; May 2, 2017.

Years: 2017 - present
Primary Mentor: Julie Locher, PhD
Co-Mentors: Kirk Habegger, PhD and Jose Fernandez, PhD

Acknowledgement and Disclaimer
The trainee's projects are supported by Grant Number T32HL105349 from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.